InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record
InterSystems, a creative data technology provider managing over one billion health records globally, today announced the launch of InterSystems IntelliCare, an AI-powered electronic health record (EHR) and healthcare information system designed to fundamentally change the way clinicians, administrators, and patients engage with healthcare technology.
Introduced at HIMSS25, IntelliCare brings next-generation AI capabilities to EHRs, delivering streamlined workflows, reduced administrative burden, enhanced patient interactions, and improved operational efficiency—all while maintaining rigorous human oversight for accuracy and safety. Built on InterSystems industry-proven TrakCare electronic medical record, IntelliCare is designed specifically for healthcare systems undergoing rapid digital transformation and seeking modern, seamlessly connected solutions without the constraints of legacy systems.
“IntelliCare represents the next step in the evolution of EHRs,” said Don Woodlock, head of global healthcare solutions at InterSystems. “By building an EHR solution with AI at its core, we’re helping healthcare providers focus on what matters: More face time with patients and less screen time.”
“AI is a seismic shift in healthcare technology,” said Jusup Halimi, President Director of EMC Healthcare. “With its advanced AI functionality and decades of proven reliability, InterSystems IntelliCare was the obvious choice to provide our hospitals with the most advanced solution available.”
InterSystems IntelliCare will streamline the EHR experience by integrating AI-driven intelligence across clinical, administrative, and financial workflows. Healthcare systems leveraging IntelliCare can benefit from:
- AI-Driven Efficiency. IntelliCare harnesses generative AI to eliminate administrative inefficiencies, allowing clinicians to spend more time interacting with patients instead of navigating complex data entry screens. Its AI Assistant enables natural language commands and automatic patient history summarization.
- Enhanced Patient Engagement. IntelliCare fosters more natural interactions between patients and providers by removing the need for data entry during office visits. With real-time capture and generation of encounter notes powered by ambient listening and AI-driven documentation tools, clinicians can focus on meaningful conversations with their patients instead of being bogged down by note-taking during visits.
- Optimized Healthcare Operations. Designed to support healthcare administrators and IT teams, IntelliCare streamlines workflows, reduces operational inefficiencies, and facilitates interoperability between systems. Using AI to prepopulate the codes required for billing within the end-to-end revenue cycle management solution helps optimize financial operations and reduce errors while accelerating reimbursement cycles.
- A Future-Ready EHR. Unlike legacy systems, IntelliCare is built with interoperability at its core, seamlessly integrating with existing healthcare IT infrastructures. The solution is available for on-premises, cloud, or SaaS deployment, ensuring flexibility for organizations of all sizes.
InterSystems IntelliCare is available now in the Middle East, Oceania, Latin American, and Southeast Asian markets. InterSystems will showcase IntelliCare at HIMSS25, offering attendees a firsthand look at its AI-powered capabilities. For a full schedule of InterSystems HIMSS25 activities or to coordinate a meeting, please visit: www.intersystems.com/himss/#meet-with-us
About InterSystems
InterSystems, a creative data technology provider, delivers a unified foundation for next-generation applications for healthcare, finance, manufacturing, and supply chain customers in more than 80 countries. Our data platforms solve interoperability, speed, and scalability problems for large organizations around the globe to unlock the power of data and allow people to perceive data in imaginative ways. Established in 1978, InterSystems is committed to excellence through its 24×7 support for customers and partners around the world. Privately held and headquartered in Boston, Massachusetts, InterSystems has 38 offices in 28 countries worldwide. For more information, please visit InterSystems.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250304321284/en/
Contacts
Zach Keating
PR@InterSystems.com
+1 617-621-0700
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom